U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of ...

Drugmakers have long argued that any threats to their profits could impact the research they do to develop new drugs.

By Steve Holland, Michael Erman and Patrick Wingrove WASHINGTON (Reuters) -U.S. President Donald Trump signed a wide-reaching ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

Tucked inside Trump's drug-pricing executive order is an apparent threat to withdraw drugmakers' medicines if they do not ...

By Chioma Obinna The Director-General of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

President Trump's executive order on drug pricing caused a surprising rally in pharmaceutical stocks. Read my analysis of PJP ...

RFK Jr. told Americans President Trump cannot be bought while also revealing Trump accepted $100 million from Big Pharma.

The move would align prescription costs in the US with the costs of other countries, according to the administration.